Skip to main content
Equibles

ONCO · Oncopeptides AB · Financials

Use ONCO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ONCO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2.0520 SEK -0.0080 (-0.39%) At close · Oct 6
Rebalance outlook locked
Market Cap
953.39M SEK
Shares
381.36M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
71.12M +124.7%
FY2025 Revenue FY2020–FY2025
Net Income
-249.59M +12.3%
FY2025 Net Income FY2020–FY2025
Gross Margin
96.55% +5pp
FY2025 Gross Margin FY2021–FY2025
Operating Margin
-315.88% +579.9pp
FY2025 Operating Margin FY2021–FY2025
Operating Cash Flow
-222.88M +14.5%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
SEK 71.12M 31.65M 35.22M 8.36M 118.3M 0
SEK 2.45M 2.66M -1.08M 6000 53.12M 0
SEK 68.67M 28.99M 36.3M 8.35M 65.17M 0
SEK 102.97M 121.19M 106.95M 217.66M 679.93M 866.21M
SEK 137.18M 136.44M 119.6M 58.1M 698.35M 456.53M
SEK 57.44M 60.84M 68.88M 84.09M 175.46M 197.66M
SEK -224.65M -283.5M -253.45M -349.35M -1.42B -1.59B
SEK 32.66M 16.62M 5.79M 883K 948K 1.49M
SEK -248.17M -284.21M -248.45M -337.68M -1.42B -1.59B
SEK — — 664K 271K 8.95M 2.25M
SEK -249.59M -284.61M -249.11M -337.95M -1.43B -1.59B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Noncurrent long-term borrowings 2025-12-31 SEK 126,681,000 ESEF Annual Report filed 2026-04-28
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.